SMart tools and Integrated methodology for cLinical dEcisions

用于临床决策的智能工具和集成方法

• 批准号: 10068571
• 金额: $ 73.17万
• 依托单位: HERIOT-WATT UNIVERSITY
• 依托单位国家: 英国
• 项目类别: EU-Funded
• 财政年份: 2023
• 资助国家: 英国
• 起止时间: 2023 至 无数据
• 项目状态: 未结题
• 来源: https://gtr.ukri.org/projects?ref=10068571
• 关键词: SMart; tools; Integrated; methodology; cLinical

Anxiety disorders’ diagnosis, decision and treatment processes are still uncertain and inconsistent especially in a fast-evolving real world where stressors affect people in different ways. SMILE aims to improve the quality of mental health management and ensure affordable services by sharing information, providing scalable digital tools, and ensuring personalized decision-making and evidence based interventions in an effective way. To achieve these goals, SMILE will develop mainly Open Knowledge Platform (OKP) and interactive gamification tools. OKP will bring together healthcare professionals, scientists, policymakers, businesses, and citizens to co design effective decision strategies and unlock access to meaningful knowledge. Gamification will provide self-assessment, learning, and self-care services for young people to develop thinking, coping, and doing skills. Hence, SMILE will be able to integrate and analysis at least 7 different diagnostic data from clinical data to daily living parameters. Also, SMILE will assist primarily clinicians and help patients through 3 decision-making tools. The analytics and predictive tools will support practitioners in understanding the associations between risk factors, and anxiety, and recommending interventions in a personalized way. The SMILE digital tools and services will be implemented and validated in eight real-life strategic case studies, in 7 different European countries: UK, Germany, Cyprus, Poland, Slovenia, Spain and Italy, to reach TRL 7. Also, a systematic upscaling method will be deployed to sustain our program and ensure the continuity in the post-project. SMILE will deliver durable legal, socio-economic, gender and environmental values for the benefit of healthcare professionals, patients, EU SMEs and society at large. Finally, SMILE has strong multidisciplinary skills and is composed of one leading research center, 5 SMEs, 3 pilot centers, 4 public universities, and 1 policymaker from 9 European countries.

焦虑症的诊断、决定和治疗过程仍然不确定和不一致，特别是在一个快速发展的现实世界中，压力源以不同的方式影响着人们。SMILE旨在通过共享信息、提供可扩展的数字工具、确保有效的个性化决策和基于证据的干预措施，提高精神卫生管理的质量，确保负担得起的服务。为了实现这些目标，SMILE将主要开发开放知识平台（OKP）和交互式游戏化工具。OKP将汇集医疗保健专业人员、科学家、政策制定者、企业和公民，共同设计有效的决策策略，并开启获取有意义知识的途径。游戏化将为年轻人提供自我评估、学习和自我照顾服务，以培养他们的思维、应对和行动技能。因此，SMILE将能够整合和分析至少7种不同的诊断数据，从临床数据到日常生活参数。此外，SMILE将主要通过3种决策工具协助临床医生和患者。分析和预测工具将支持从业者理解风险因素和焦虑之间的联系，并以个性化的方式推荐干预措施。SMILE数字工具和服务将在七个不同的欧洲国家（英国、德国、塞浦路斯、波兰、斯洛文尼亚、西班牙和意大利）的八个现实战略案例研究中实施和验证，以达到TRL 7。此外，我们将采用系统的升级方法来维持我们的项目，并确保项目后的连续性。SMILE将为医疗保健专业人员、患者、欧盟中小企业和整个社会带来持久的法律、社会经济、性别和环境价值。最后，SMILE拥有强大的多学科技能，由一个领先的研究中心、5个中小企业、3个试点中心、4所公立大学和来自9个欧洲国家的1名决策者组成。